Skip to main content
OpenTrials
Completed

NCT Number: NCT00975845

BioCleanse Tibialis Tendon Anterior Cruciate Ligament (ACL) Study

To compare the outcome of Anterior Cruciate Ligament (ACL) reconstruction performed using the tibialis allograft to historical outcomes of ACL reconstruction patients and to establish if any correlation exists between the age of the graft donor and the clinical outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anterior Cruciate Ligament Rupture Anterior Cruciate Ligament Injuries Knee Injuries Leg Injuries Wounds and Injuries

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

The Orthopedic Clinic, Assoc

Phoenix, Arizona, 85016, United States

About this study

This is a single-arm, single site, pilot study in patients with a ruptured ACL. A total of fifty (50) subjects will be enrolled in this trial. All patients will have been scheduled to undergo ACL reconstruction and will receive a BioCleanse Tibialis allograft as part of the normal standard of care practiced by the treating surgeon. Follow up is for 2 years.

However, there is no assignment of graft, specific to donor age, to the patients. All treatment will follow standard of care and this study assumes that there will be a normal distribution of graft donor ages, from 18 to 65 years of age.

Patient outcomes will be compared between the 2 groups of tendon donor ages. Neither the surgeon nor the patient will be aware of the age of the graft donor, per typical standard of care.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Study subjects will be limited to those subjects undergoing allograft anterior cruciate ligament reconstruction surgery
  • Meniscal injuries may be included
  • Isolated, unilateral anterior cruciate ligament injury.
  • All subjects will have a minimum age of eighteen (18) years and a maximum of sixty (60) years.
  • Both male and non-pregnant female subjects will be included.
  • To facilitate follow-up, study subjects will be limited to the local geographic area of the study site and be willing to use the rehabilitation facility and physical therapy schedule assigned by the surgeon.
  • All subjects must be able to read, write, and comprehend instructions and guidelines in English and understand (and sign as an acknowledgment of their understanding) an informed consent declaration.

Exclusion criteria

  • No chondral defects
  • Failure to comply with or meet all of the inclusion criteria listed above.
  • Autograft anterior cruciate ligament surgery on either knee.
  • Anterior cruciate ligament injury on contra-lateral leg at any time
  • Multi-ligament reconstruction
  • Inability to comply with all requirements of this investigation, as well as follow the instructions of the physician.
  • Significant systemic disease or conditions which impact overall health or well being or which necessitate chronic medication use.
  • Revision anterior cruciate ligament surgery to either knee at anytime
  • Exhibiting signs of moderate to severe degenerative joint disease in addition to requiring anterior cruciate ligament surgery.
  • Concomitant injuries to the knee or lower extremities requiring treatment, per surgeon's discretion.

Treatment and study plan

BioCleanse Tibialis tendon

Other

Outcomes of anterior cruciate replacement will be evaluated

Primary outcomes

  1. Objective International Knee Documentation Committee (IKDC) Exam

    Time frame: pre-op, 2 months, 4 months, 6 months, 12 months, 24 months

    The International Knee Documentation Committee (IKDC) is a knee-specific patient-reported outcome measure. This is an indexed score form 0-100, with 0 being the worst possible status and 100 indicating no dysfunction, disability or pain.

Secondary outcomes

  1. Subjective quality of life scores

    Time frame: pre-op, 2 months, 4 months, 6 months, 12 months, and 24 months

    The SF36 measures the quality life as reported by the paritricpantm, and is an indexed score form 0 - 100. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability

Sponsors and collaborators

Lead sponsor

RTI Surgical

Industry

Registry information

Official study title

A Prospective, Double-Blind Evaluation of the Effects of BioCleanse Tibialis Tendon Allograft and Donor Age on Clinical Outcomes of ACL Reconstruction

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Sep 11, 2009
Registry last updated
Nov 1, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.